150 related articles for article (PubMed ID: 26722489)
1. A meta-analysis of xeroderma pigmentosum gene D Ls751Gln polymorphism and susceptibility to hepatocellular carcinoma.
Wang Y; Zhao Y; Zhang A; Ma J; Wang Z; Zhang X
Int J Clin Exp Pathol; 2015; 8(10):12949-54. PubMed ID: 26722489
[TBL] [Abstract][Full Text] [Related]
2. Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Medicine (Baltimore); 2014 Dec; 93(29):e330. PubMed ID: 25546681
[TBL] [Abstract][Full Text] [Related]
3. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.
Ding DP; Ma WL; He XF; Zhang Y
Mol Biol Rep; 2012 Mar; 39(3):2533-40. PubMed ID: 21667112
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of excision repair gene XPD Lys751Gln and hOGG1 Ser326Cys might not be associated with hepatocellular carcinoma risk: a meta-analysis.
Zhang RC; Mou SH
Tumour Biol; 2013 Apr; 34(2):901-7. PubMed ID: 23271362
[TBL] [Abstract][Full Text] [Related]
5. [Association of the xeroderma pigmentosum group D DNA repair gene with hepatocellular carcinoma].
Zhang JJ; Ma JZ
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):683-7. PubMed ID: 23207233
[TBL] [Abstract][Full Text] [Related]
6. XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
Cui J; Li D; Shen L; Zhang W; Xu X
Tumour Biol; 2014 Jul; 35(7):6335-41. PubMed ID: 24652592
[TBL] [Abstract][Full Text] [Related]
7. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
8. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk.
Long XD; Ma Y; Zhou YF; Yao JG; Ban FZ; Huang YZ; Huang BC
BMC Cancer; 2009 Nov; 9():400. PubMed ID: 19919686
[TBL] [Abstract][Full Text] [Related]
9. XPD Lys
Yang QI; Wei YF; Zhang Y; Huang GM
Exp Ther Med; 2015 Jun; 9(6):2406-2414. PubMed ID: 26136996
[TBL] [Abstract][Full Text] [Related]
10. Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis.
Yuan H; Niu YM; Wang RX; Li HZ; Chen N
Genet Mol Res; 2011 Nov; 10(4):3356-64. PubMed ID: 22179996
[TBL] [Abstract][Full Text] [Related]
11. Association between XPD Lys751Gln polymorphism and bladder cancer susceptibility: an updated and cumulative meta-analysis based on 6,836 cases and 8,251 controls.
Li S; Zeng XT; Ruan XL; Liu TZ; Wang XH
Mol Biol Rep; 2014 Jun; 41(6):3621-9. PubMed ID: 24510389
[TBL] [Abstract][Full Text] [Related]
12. Implication of polymorphisms in DNA repair genes in prognosis of hepatocellular carcinoma.
Yue AM; Xie ZB; Guo SP; Wei QD; Yang XW
Asian Pac J Cancer Prev; 2013; 14(1):355-8. PubMed ID: 23534753
[TBL] [Abstract][Full Text] [Related]
13. XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis.
Zhou Q; Fu Y; Wen L; Deng Y; Chen J; Liu K
Technol Cancer Res Treat; 2021; 20():1533033821990046. PubMed ID: 33517857
[TBL] [Abstract][Full Text] [Related]
14. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies.
Yin QH; Liu C; Hu JB; Meng RR; Li L; Wang YJ
Asian Pac J Cancer Prev; 2013; 14(1):231-6. PubMed ID: 23534729
[TBL] [Abstract][Full Text] [Related]
15. Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk.
Guo LY; Jin XP; Niu W; Li XF; Liu BH; Wang YL
Asian Pac J Cancer Prev; 2012; 13(9):4423-6. PubMed ID: 23167354
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
Ma Q; Qi C; Tie C; Guo Z
Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
[TBL] [Abstract][Full Text] [Related]
17. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
[TBL] [Abstract][Full Text] [Related]
18. Association of XPD Lys751Gln polymorphism with head and neck cancer susceptibility: evidence from 11,443 subjects.
Lin H; Lin D; Zheng C
Diagn Pathol; 2014 Jan; 9():15. PubMed ID: 24443924
[TBL] [Abstract][Full Text] [Related]
19. XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis.
Guo XF; Wang J; Lei XF; Zeng YP; Dong WG
Intern Med; 2015; 54(3):251-9. PubMed ID: 25748732
[TBL] [Abstract][Full Text] [Related]
20. Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma.
Wu JS; Chen YP; Wang LC; Yang YJ; Deng CW; Hou BX; He ZL; Chen JX
Genet Mol Res; 2014 May; 13(2):3812-8. PubMed ID: 24938468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
